News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
736,523 Results
Type
Article (49820)
Company Profile (278)
Press Release (686425)
Multimedia
Podcasts (62)
Webinars (12)
Section
Business (212325)
Career Advice (2098)
Deals (36536)
Drug Delivery (104)
Drug Development (83639)
Employer Resources (173)
FDA (16984)
Job Trends (15720)
News (359328)
Policy (34699)
Tag
Academia (2782)
Accelerated approval (5)
Adcomms (23)
Allergies (88)
Alliances (51612)
ALS (93)
Alzheimer's disease (1439)
Antibody-drug conjugate (ADC) (129)
Approvals (16987)
Artificial intelligence (276)
Autoimmune disease (22)
Automation (16)
Bankruptcy (373)
Best Places to Work (12096)
BIOSECURE Act (19)
Biosimilars (106)
Biotechnology (191)
Bladder cancer (80)
Brain cancer (28)
Breast cancer (290)
Cancer (2314)
Cardiovascular disease (186)
Career advice (1761)
Career pathing (31)
CAR-T (154)
Cell therapy (429)
Cervical cancer (21)
Clinical research (67920)
Collaboration (859)
Compensation (532)
Complete response letters (21)
COVID-19 (2717)
CRISPR (41)
C-suite (252)
Cystic fibrosis (101)
Data (2233)
Decentralized trials (2)
Denatured (28)
Depression (50)
Diabetes (277)
Diagnostics (6583)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (122)
Drug pricing (105)
Drug shortages (28)
Duchenne muscular dystrophy (95)
Earnings (88782)
Editorial (39)
Employer branding (21)
Employer resources (147)
Events (117421)
Executive appointments (740)
FDA (18290)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (769)
Gene editing (108)
Generative AI (25)
Gene therapy (308)
GLP-1 (760)
Government (4686)
Grass and pollen (4)
Guidances (65)
Healthcare (19902)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (119)
Indications (30)
Infectious disease (2865)
Inflammatory bowel disease (142)
Inflation Reduction Act (8)
Influenza (53)
Intellectual property (96)
Interviews (319)
IPO (16875)
IRA (41)
Job creations (4045)
Job search strategy (1501)
Kidney cancer (10)
Labor market (38)
Layoffs (485)
Leadership (18)
Legal (8465)
Liver cancer (78)
Lung cancer (329)
Lymphoma (155)
Machine learning (7)
Management (58)
Manufacturing (311)
MASH (70)
Medical device (14384)
Medtech (14389)
Mergers & acquisitions (20211)
Metabolic disorders (720)
Multiple sclerosis (82)
NASH (16)
Neurodegenerative disease (99)
Neuropsychiatric disorders (31)
Neuroscience (2002)
NextGen: Class of 2025 (6911)
Non-profit (4740)
Now hiring (39)
Obesity (385)
Opinion (218)
Ovarian cancer (76)
Pain (92)
Pancreatic cancer (84)
Parkinson's disease (153)
Partnered (21)
Patents (236)
Patient recruitment (114)
Peanut (48)
People (60163)
Pharmaceutical (68)
Pharmacy benefit managers (19)
Phase I (21134)
Phase II (29839)
Phase III (22301)
Pipeline (1212)
Policy (141)
Postmarket research (2741)
Preclinical (9025)
Press Release (67)
Prostate cancer (109)
Psychedelics (32)
Radiopharmaceuticals (256)
Rare diseases (390)
Real estate (6304)
Recruiting (65)
Regulatory (23711)
Reports (46)
Research institute (2482)
Resumes & cover letters (359)
Rett syndrome (5)
RNA editing (5)
RSV (44)
Schizophrenia (76)
Series A (131)
Series B (87)
Service/supplier (13)
Sickle cell disease (53)
Special edition (14)
Spinal muscular atrophy (152)
Sponsored (31)
Startups (3831)
State (2)
Stomach cancer (14)
Supply chain (71)
Tariffs (39)
The Weekly (32)
Vaccines (729)
Venture capitalists (42)
Weight loss (262)
Women's health (38)
Worklife (16)
Date
Today (209)
Last 7 days (908)
Last 30 days (2696)
Last 365 days (33683)
2025 (10958)
2024 (36109)
2023 (41146)
2022 (52382)
2021 (57101)
2020 (55911)
2019 (48795)
2018 (36938)
2017 (33747)
2016 (33564)
2015 (39609)
2014 (33324)
2013 (28558)
2012 (30846)
2011 (31551)
2010 (29924)
Location
Africa (794)
Alabama (54)
Alaska (7)
Arizona (240)
Arkansas (14)
Asia (41017)
Australia (6757)
California (6191)
Canada (2026)
China (543)
Colorado (278)
Connecticut (291)
Delaware (151)
Europe (88886)
Florida (920)
Georgia (214)
Idaho (61)
Illinois (576)
India (26)
Indiana (314)
Iowa (11)
Japan (165)
Kansas (107)
Kentucky (24)
Louisiana (11)
Maine (62)
Maryland (934)
Massachusetts (4668)
Michigan (227)
Minnesota (405)
Mississippi (2)
Missouri (83)
Montana (27)
Nebraska (25)
Nevada (65)
New Hampshire (68)
New Jersey (1759)
New Mexico (29)
New York (1768)
North Carolina (1036)
North Dakota (8)
Northern California (2700)
Ohio (206)
Oklahoma (14)
Oregon (35)
Pennsylvania (1387)
Puerto Rico (12)
Rhode Island (35)
South America (1185)
South Carolina (24)
South Dakota (1)
Southern California (2322)
Tennessee (103)
Texas (921)
United States (23634)
Utah (184)
Virginia (150)
Washington D.C. (65)
Washington State (572)
West Virginia (3)
Wisconsin (56)
736,523 Results for "globus medical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Globus Medical Reports Fourth Quarter and Full Year 2024 Results
February 21, 2025
·
24 min read
Press Releases
Globus Medical to Acquire Nevro Corp. to Expand Treatment Options for Patients
February 6, 2025
·
8 min read
Business
Globus Medical Reports First Quarter 2024 Results
Globus Medical, Inc., a leading musculoskeletal solutions company, announced its financial results for the quarter ended March 31, 2024.
May 7, 2024
·
19 min read
Press Releases
Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results
January 9, 2025
·
8 min read
Press Releases
Globus Medical Reports Third Quarter 2024 Results
November 6, 2024
·
22 min read
Business
Globus Medical Reports Fourth Quarter and Full Year 2023 Results
Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced its financial results for the fourth quarter and year ended December 31, 2023.
February 20, 2024
·
22 min read
Business
Globus Medical Schedules Third Quarter Earnings Release and Conference Call
October 15, 2024
·
4 min read
Business
Globus Medical Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call
Globus Medical, Inc., a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full year ended December 31, 2023 after the market close on Tuesday, February 20, 2024.
February 13, 2024
·
4 min read
Business
Globus Medical Reports Third Quarter 2023 Results
Globus Medical, Inc., a leading musculoskeletal solutions company, announced its financial results for the quarter ended September 30, 2023.
November 7, 2023
·
20 min read
Press Releases
Globus Medical Launches ADIRA™ XLIF™ Plate System
August 23, 2024
·
6 min read
1 of 73,653
Next
